Skip to main content

Table 2 Statistical differences between patients with unexplained female sterility, patients with RPL and control subjects

From: Hyperhomocysteinemia in women with unexplained sterility or recurrent early pregnancy loss from Southern Italy: a preliminary report

  Hcy (μM/ml) p Serum folate (ng/ml) P Serum vit. B 12 (pg/ml) p MTHFR C677T heterozigosity p MTHFR C677T homozigosity p
UFS vs CG 21.05 ± 8.78 vs 7.85 ± 3.31 <0.01, s 6.70 ± 4.50 vs 20.10 ± 9.44 <0.01, s 648 ± 162 vs 664 ± 175 0.35, ns 5/20 vs 9/20 0.32, ns 15/20 vs 3/20 <0.01, s
UFS vs RPL 21.05 ± 8.78 vs 19.20 ± 6.14 0.44, ns 6.70 ± 4.50 vs 6.10 ± 2.81 0.007, s 648 ± 162 vs 608 ± 154 0.42, ns 5/20 vs 3/20 0.69, ns 15/20 vs 17/20 0.69, ns
RPL vs CG 19.20 ± 6.14 vs 7.85 ± 3.31 <0.01, s 6.10 ± 2.81 vs 20.10 ± 9.44 <0.01, s 608 ± 154 vs vs 664 ± 175 0.20, ns 3/20 vs 9/20 0.08, ns 17/20 vs 3/20 <0.01, s
  1. Hcy: homocysteine
  2. MTHFR: methylenetetrahydrofolate reductase
  3. UFS: unexplained female sterility group
  4. RPL: recurrent pregnancy loss group
  5. CG: control group
  6. ns: not significant
  7. s: significant